Open house Arzneimittelrabattverträge zum Wirkstoff Indacaterol und Glycopyrroniumbromid, ATC R03AL04

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - The health insurance fund offers all interested pharmaceutical companies discount contracts with the above-mentioned active ingredient without any selection decision. Contract award takes place as part of an "open-house model". The contracts offered are not exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The health insurance fund. In the open-house model, uniform conditions apply to all participants. Contract contents, terms and conditions and access procedures are uniform—individual negotiations are not conducted. Contract terms are a maximum of 24 months; the earliest contract start date is 01.12.2026. All contracts end no later than 24 months after the day of the earliest contract start date, regardless of the date of the respective contract award. Entry and/or contract award can take place within the 24-month period, in each case on the first day of each month. There is a right of termination, in each case 6 weeks before the end of the month, in accordance with the provisions of the contract. Further information on the possibilities for termination is contained in the…

TENDER BRIEF

TENDER DOCUMENTS